May 11, 2026 04:01PM

May 7, 2026 08:04AM

May 7, 2026 08:00AM

Mar 17, 2026 05:00PM

Mar 5, 2026 04:01PM

Dec 22, 2025 08:00AM

Dec 22, 2025 08:00AM ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer

Nov 10, 2025 08:00AM

Sep 9, 2025 08:00AM

Sep 9, 2025 08:00AM

Aug 11, 2025 08:00AM

Jul 21, 2025 08:01AM

Jul 21, 2025 08:00AM

May 14, 2025 07:52AM ArriVent BioPharma (AVBP) PT Raised to $40 at H.C. Wainwright

May 12, 2025 08:00AM

Mar 7, 2025 06:42AM

Mar 3, 2025 07:00AM

Nov 14, 2024 08:00AM

Sep 9, 2024 12:07PM

Sep 9, 2024 12:05PM

Mar 28, 2024 08:30PM InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib

Mar 28, 2024 04:05PM

Jan 5, 2024 04:20PM

323,590 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All